Article
[NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2022
Maeda Takahiro
Abstract excerpt
Next-generation sequencing (NGS)-based multigene panel testing enables assessment of the mutational status of a few hundred genes associated with cancer pathogenesis. Although such tests have been approved by the Pharmaceuticals and Medical Devices Agency for use in patients with treatment-refractory solid tumors,there are no currently available tests for hematologic malignancies. The resultant information from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
